Bottom line
FBT vs GNOM: the short answer
FBT (First Trust NYSE Arca Biotechnology Index Fund) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 31% of their top holdings (by weight) are shared.
GNOM is cheaper at 0.5% vs 0.55% — a difference of $5.00 a year per $10,000 invested.
Over five years, FBT returned +4.3% a year vs −13.3% for GNOM.
Updated Nov 19, 2026
FBT vs GNOM side by side
| FBT | GNOM | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | First Trust | Global X |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.55% | 0.5% |
| Annual cost per $10k | $55 | $50 |
| 10-yr cost on $10k (prospectus) | — | $628 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +24.1% | +19.0% |
| 5-yr return (annualized) | +4.3% | −13.3% |
| 10-yr return (annualized) | +6.3% | — |
| Best quarter | +27.8% | +38.8% |
| Worst quarter | −22.5% | −24.2% |
| Net assets (fund) | $2.8B | $55.8M |
| Number of holdings | 32 | 51 |
| Portfolio turnover | 37% | 34% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FBT | GNOM | Difference |
|---|---|---|---|
| 2025 | +24.1% | +19.0% | +5.1% |
| 2024 | +5.8% | −16.2% | +21.9% |
| 2023 | +2.3% | −8.6% | +10.9% |
| 2022 | −4.6% | −36.1% | +31.5% |
| 2021 | −3.6% | −16.0% | +12.4% |
| 2020 | +12.9% | +51.6% | −38.7% |
Source: Fund prospectus bar charts
Holdings overlap
8 of FBT's top 25 holdings also appear in GNOM's top 25.
| Holding | FBT | GNOM |
|---|---|---|
| Veracyte Inc | 5.10% | 3.64% |
| Illumina Inc | 3.92% | 4.82% |
| Natera Inc | 3.79% | 4.15% |
| Bio-techne Corp | 3.43% | 3.41% |
| Arrowhead Pharmaceuticals Inc | 3.38% | 4.07% |
| Vertex Pharmaceuticals Inc | 3.07% | 3.95% |
| Biomarin Pharmaceutical Inc | 2.83% | 4.09% |
| Biontech Se | 2.63% | 3.41% |
Source: SEC Form N-PORT
FBT top 10
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Illumina Inc — 3.92%
- Krystal Biotech Inc — 3.87%
- Natera Inc — 3.79%
- Axsome Therapeutics Inc — 3.71%
- Neurocrine Biosciences Inc — 3.53%
GNOM top 10
- Guardant Health, Inc. — 5.59%
- Illumina, Inc. — 4.82%
- Natera, Inc. — 4.15%
- Biomarin Pharmaceutical Inc. — 4.09%
- Arrowhead Pharmaceuticals, Inc. — 4.07%
- Legend Biotech Corp — 4.05%
- Praxis Precision Medicines Inc — 4.01%
- Twist Bioscience Corp — 3.97%
- Vertex Pharmaceuticals Incorporated — 3.95%
- CRISPR Therapeutics AG — 3.85%
FAQ
What is the difference between FBT and GNOM?
Which is cheaper, FBT or GNOM?
Should I own both FBT and GNOM?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.